Equities

Alvotech SA

Alvotech SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (ISK)1,690.00
  • Today's Change10.00 / 0.60%
  • Shares traded372.24k
  • 1 Year change+30.50%
  • Beta--
Data delayed at least 15 minutes, as of Nov 13 2024 16:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments116618
Total Receivables, Net877154
Total Inventory747139
Prepaid expenses22219.32
Other current assets, total--0.85--
Total current assets195231120
Property, plant & equipment, net357268205
Goodwill, net121212
Intangibles, net192622
Long term investments184955
Note receivable - long term113.291.48
Other long term assets2.245.781.66
Total assets950828598
LIABILITIES
Accounts payable814929
Accrued expenses635442
Notes payable/short-term debt000
Current portion long-term debt/capital leases482510
Other current liabilities, total703931
Total current liabilities261167112
Total long term debt1,028780513
Total debt1,075805523
Deferred income tax0.050.310.15
Minority interest------
Other liabilities, total594445109
Total liabilities1,8831,393734
SHAREHOLDERS EQUITY
Common stock2.282.130.14
Additional paid-in capital1,2301,0581,000
Retained earnings (accumulated deficit)(2163)(1624)(1141)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(1.53)(1.44)4.67
Total equity(932)(564)(136)
Total liabilities & shareholders' equity950828598
Total common shares outstanding26725225
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.